Company Profile · Healthcare

Hubei Jumpcan Pharmaceutical Co Ltd

600566 · Shanghai
Country
China
IPO date
Aug 1, 2001
Employees
4,137
Buffett Score
91/100
Elite
Market capCN¥23.62B
Revenue (TTM)CN¥5.8B
EBITDACN¥2.15B
Profit margin31.69%
ROE13.42%
P/E (TTM)12.82
Forward P/E0
EPSCN¥2.00
Dividend yield7%
52-week rangeCN¥21.13 – CN¥29.60

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.